FREMONT, Calif., Jan. 3, 2024 /PRNewswire/ — The automotive industry is witnessing a significant shift in consumer preferences driven by the increasing prevalence of electric vehicles (EVs) globally. Environmental concerns are steering consumers toward sustainable transportation, leading to a notable surge in EV adoption. According to the International Energy Agency’s EV Outlook 2023, “EV sales… Continue reading EV Battery Materials and Related Technologies Set to Fuel the Electric Vehicle Battery Market to $93.94 Billion by 2026: BIS Research
Category: Newswire
Ocean Beach Resort & SPA Joins ASTON Collection Hotels Under Archipelago International
MALINDI, Kenya, Jan. 3, 2024 /PRNewswire/ — Ocean Beach Resort & SPA, a distinguished five-star haven on the sandy dunes beach, is thrilled to announce its integration into the esteemed ASTON Collection Hotels, commencing January 1st, 2024. As part of the renowned Archipelago International—the largest hotel operator in Southeast Asia—this marks a milestone in redefining… Continue reading Ocean Beach Resort & SPA Joins ASTON Collection Hotels Under Archipelago International
Hansa Biopharma provides update on business and key financials ahead of the JP Morgan Healthcare Conference
Strong revenue generation in Q4 2023, including SEK 43m in Idefirix® product sales supported by growth in new markets such as U.K., Germany, and Spain Encouraging first results from first-in-human trial of HNSA-5487, Hansa’s lead candidate from the NiceR program for repeat dosing Initiation of phase 1b trial of imlifidase as pre-treatment to Sarepta’s SRP-9001 in DMD … Continue reading Hansa Biopharma provides update on business and key financials ahead of the JP Morgan Healthcare Conference
Hansa Biopharma provides update on business and key financials ahead of the JP Morgan Healthcare Conference
Strong revenue generation in Q4 2023, including SEK 43m in Idefirix® product sales supported by growth in new markets such as U.K., Germany, and Spain Encouraging first results from first-in-human trial of HNSA-5487, Hansa’s lead candidate from the NiceR program for repeat dosing Initiation of phase 1b trial of imlifidase as pre-treatment to Sarepta’s SRP-9001 in DMD … Continue reading Hansa Biopharma provides update on business and key financials ahead of the JP Morgan Healthcare Conference
Baseus Invites Consumers to Come See and Be Part of an Exciting Technological Revolution at the CES 2024 Event in Las Vegas
LAS VEGAS, Jan. 6, 2024 /PRNewswire/ — Baseus Technology, a leading global consumer electronics brand, is inviting consumers to join them at the CES 2024 event in Las Vegas where they will be unveiling a range of advanced and innovative Baseus technologies that will transform and rejuvenate the tech landscape. Some of the cutting-edge products… Continue reading Baseus Invites Consumers to Come See and Be Part of an Exciting Technological Revolution at the CES 2024 Event in Las Vegas
Menarini Group und Insilico Medicine schließen exklusiven globalen Lizenzvertrag für neuen KAT6-Inhibitor für mögliche Behandlungen von Brustkrebs und andere onkologische Indikationen ab
KAT6 ist ein neues Target bei hormonsensitiven Brustkrebstumoren und anderen Krebsarten. Eine Überexpression von KAT6A/B wird mit schlechten klinischen Ergebnissen bei Patientinnen mit ER+/HER2-Brustkrebs – einem der häufigsten Subtypen – in Verbindung gebracht. Das Molekül zeigte hohe vorklinische Aktivität. Insilico präsentierte auf dem San Antonio Brustkrebs-Symposium Anfang Dezember Daten zu diesem neuen Molekül. Die Vereinbarung umfasst Voraus- und… Continue reading Menarini Group und Insilico Medicine schließen exklusiven globalen Lizenzvertrag für neuen KAT6-Inhibitor für mögliche Behandlungen von Brustkrebs und andere onkologische Indikationen ab
Menarini Group et Insilico Medicine concluent un accord mondial de licence exclusive pour un nouvel inhibiteur de KAT6 destiné au traitement potentiel du cancer du sein et à d’autres indications en oncologie
KAT6 est une cible émergente dans les tumeurs mammaires hormonosensibles et d’autres cancers. La surexpression de KAT6A/B est corrélée à de mauvais résultats cliniques chez les patientes atteintes d’un cancer du sein ER+/HER2-, le sous-type le plus courant. La molécule a démontré une forte activité préclinique. Insilico a présenté des données sur cette nouvelle molécule lors du… Continue reading Menarini Group et Insilico Medicine concluent un accord mondial de licence exclusive pour un nouvel inhibiteur de KAT6 destiné au traitement potentiel du cancer du sein et à d’autres indications en oncologie
Menarini Group e Insilico Medicine assinam acordo de licença global exclusivo para um novo inibidor de KAT6 para possível tratamento de câncer de mama e outras indicações oncológicas
KAT6 é um alvo emergente em tumores de mama sensíveis a hormônios e outros cânceres. A superexpressão de KAT6A/B está correlacionada com resultados clínicos ruins em pacientes com câncer de mama ER+/HER2-, o subtipo mais comum. A molécula demonstrou uma forte atividade pré-clínica. A Insilico apresentou dados sobre a nova molécula no Simpósio sobre Câncer de Mama… Continue reading Menarini Group e Insilico Medicine assinam acordo de licença global exclusivo para um novo inibidor de KAT6 para possível tratamento de câncer de mama e outras indicações oncológicas
Copa de Falcoaria AlUla inaugural celebra nove dias de esportes espetaculares e prêmios com quebra de recordes
A Mugharia Heritage Sports Village da AlUla recebeu 2.000 falcões de elite e seus proprietários durante a primeira edição do torneio, realizada de 28 de dezembro a 5 de janeiro O concurso internacional atraiu falcoeiros líderes de todo o mundo para uma série de corridas emocionantes e concursos tradicionais de beleza de falcões ‘best-in-show’ ALULA, Arábia Saudita, 6… Continue reading Copa de Falcoaria AlUla inaugural celebra nove dias de esportes espetaculares e prêmios com quebra de recordes
La primera Copa Halcón de AlUla celebra nueve días de deportes patrimoniales espectaculares con premios sin precedentes
La Mugharia Heritage Sports Village de AlUla fue el escenario de la primera edición del torneo, celebrada del 28 de diciembre al 5 de enero, en la que participaron 2000 halcones de élite y sus propietarios. Un concurso internacional que atrajo a destacados cetreros de todo el mundo para participar en una serie de emocionantes carreras… Continue reading La primera Copa Halcón de AlUla celebra nueve días de deportes patrimoniales espectaculares con premios sin precedentes